Format

Send to

Choose Destination
Cancer Commun (Lond). 2019 Sep 27;39(1):51. doi: 10.1186/s40880-019-0395-3.

Poor outcomes of immunoglobulin D multiple myeloma patients in the era of novel agents: a single-center experience.

Author information

1
Department of Hematology, Jinling Hospital, School of Medicine, Nanjing University, 305 East Zhongshan Road, Xuanwu District, Nanjing, 210002, Jiangsu, P. R. China.
2
Department of Hematology, Jinling Hospital, School of Medicine, Nanjing University, 305 East Zhongshan Road, Xuanwu District, Nanjing, 210002, Jiangsu, P. R. China. zhaiyongping00@163.com.

Supplemental Content

Full text links

Icon for Wiley Icon for PubMed Central
Loading ...
Support Center